China Pharma Holdings, Inc. (CPHI)
USD 1.7
(13.04%)
USD 1.7
(13.04%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 16.46 Million USD | -7.39% |
| 2022 | 17.78 Million USD | -21.48% |
| 2021 | 22.64 Million USD | 7.25% |
| 2020 | 21.11 Million USD | -5.02% |
| 2019 | 22.23 Million USD | -51.0% |
| 2018 | 45.37 Million USD | -24.31% |
| 2017 | 59.95 Million USD | -23.65% |
| 2016 | 78.52 Million USD | -19.24% |
| 2015 | 97.22 Million USD | -26.39% |
| 2014 | 132.08 Million USD | -16.2% |
| 2013 | 157.61 Million USD | -3.45% |
| 2012 | 163.23 Million USD | 4.38% |
| 2011 | 156.39 Million USD | 18.7% |
| 2010 | 131.75 Million USD | 30.52% |
| 2009 | 100.94 Million USD | 33.75% |
| 2008 | 75.47 Million USD | 72.68% |
| 2007 | 43.7 Million USD | 53.28% |
| 2006 | 28.51 Million USD | 62.93% |
| 2005 | 17.5 Million USD | 20834507.14% |
| 2004 | 84.00 USD | -99.97% |
| 2003 | 298.62 Thousand USD | -29.85% |
| 2002 | 425.67 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 16.19 Million USD | -1.69% |
| 2024 Q2 | 14.26 Million USD | -11.92% |
| 2023 Q3 | 15.35 Million USD | -2.24% |
| 2023 Q1 | 17.35 Million USD | -2.41% |
| 2023 Q2 | 15.7 Million USD | -9.52% |
| 2023 FY | 16.46 Million USD | -7.39% |
| 2023 Q4 | 16.46 Million USD | 7.27% |
| 2022 FY | 17.78 Million USD | -21.48% |
| 2022 Q4 | 17.78 Million USD | 9.75% |
| 2022 Q2 | 17.91 Million USD | -14.85% |
| 2022 Q1 | 21.04 Million USD | -7.09% |
| 2022 Q3 | 16.2 Million USD | -9.57% |
| 2021 Q1 | 19.84 Million USD | -6.02% |
| 2021 Q2 | 19.94 Million USD | 0.49% |
| 2021 Q3 | 18.18 Million USD | -8.83% |
| 2021 Q4 | 22.64 Million USD | 24.56% |
| 2021 FY | 22.64 Million USD | 7.25% |
| 2020 Q3 | 21.12 Million USD | -8.81% |
| 2020 FY | 21.11 Million USD | -5.02% |
| 2020 Q1 | 22.43 Million USD | 0.9% |
| 2020 Q2 | 23.16 Million USD | 3.25% |
| 2020 Q4 | 21.11 Million USD | -0.03% |
| 2019 Q4 | 22.23 Million USD | -44.27% |
| 2019 Q1 | 45.24 Million USD | -0.3% |
| 2019 FY | 22.23 Million USD | -51.0% |
| 2019 Q2 | 43.03 Million USD | -4.89% |
| 2019 Q3 | 39.9 Million USD | -7.27% |
| 2018 Q3 | 52.53 Million USD | -9.9% |
| 2018 Q2 | 58.3 Million USD | -6.15% |
| 2018 FY | 45.37 Million USD | -24.31% |
| 2018 Q1 | 62.12 Million USD | 3.63% |
| 2018 Q4 | 45.37 Million USD | -13.62% |
| 2017 Q2 | 77.12 Million USD | -1.3% |
| 2017 Q1 | 78.14 Million USD | -0.48% |
| 2017 FY | 59.95 Million USD | -23.65% |
| 2017 Q4 | 59.95 Million USD | -20.06% |
| 2017 Q3 | 74.99 Million USD | -2.76% |
| 2016 Q2 | 91.97 Million USD | -5.21% |
| 2016 Q1 | 97.03 Million USD | -0.2% |
| 2016 FY | 78.52 Million USD | -19.24% |
| 2016 Q4 | 78.52 Million USD | -10.17% |
| 2016 Q3 | 87.4 Million USD | -4.97% |
| 2015 FY | 97.22 Million USD | -26.39% |
| 2015 Q4 | 97.22 Million USD | -13.72% |
| 2015 Q3 | 112.68 Million USD | -7.05% |
| 2015 Q2 | 121.23 Million USD | -3.14% |
| 2015 Q1 | 125.16 Million USD | -5.24% |
| 2014 Q2 | 146.02 Million USD | -5.39% |
| 2014 Q4 | 132.08 Million USD | -6.01% |
| 2014 FY | 132.08 Million USD | -16.2% |
| 2014 Q1 | 154.34 Million USD | -2.07% |
| 2014 Q3 | 140.53 Million USD | -3.76% |
| 2013 Q1 | 159.25 Million USD | -2.44% |
| 2013 Q4 | 157.61 Million USD | -3.0% |
| 2013 FY | 157.61 Million USD | -3.45% |
| 2013 Q3 | 162.48 Million USD | 2.24% |
| 2013 Q2 | 158.93 Million USD | -0.2% |
| 2012 FY | 163.23 Million USD | 4.38% |
| 2012 Q1 | 163.62 Million USD | 4.63% |
| 2012 Q2 | 164.88 Million USD | 0.77% |
| 2012 Q3 | 166.04 Million USD | 0.7% |
| 2012 Q4 | 163.23 Million USD | -1.69% |
| 2011 Q4 | 156.39 Million USD | 4.88% |
| 2011 Q2 | 143.43 Million USD | 4.53% |
| 2011 Q3 | 149.11 Million USD | 3.96% |
| 2011 Q1 | 137.22 Million USD | 4.15% |
| 2011 FY | 156.39 Million USD | 18.7% |
| 2010 Q3 | 121.54 Million USD | 4.9% |
| 2010 Q2 | 115.86 Million USD | 7.13% |
| 2010 Q1 | 108.15 Million USD | 7.15% |
| 2010 FY | 131.75 Million USD | 30.52% |
| 2010 Q4 | 131.75 Million USD | 8.4% |
| 2009 FY | 100.94 Million USD | 33.75% |
| 2009 Q1 | 80.42 Million USD | 6.56% |
| 2009 Q2 | 85.92 Million USD | 6.84% |
| 2009 Q3 | 95.3 Million USD | 10.92% |
| 2009 Q4 | 100.94 Million USD | 5.91% |
| 2008 FY | 75.47 Million USD | 72.68% |
| 2008 Q2 | 65.11 Million USD | 28.96% |
| 2008 Q3 | 66.82 Million USD | 2.63% |
| 2008 Q4 | 75.47 Million USD | 12.94% |
| 2008 Q1 | 50.49 Million USD | 15.52% |
| 2007 Q4 | 43.7 Million USD | 1.92% |
| 2007 FY | 43.7 Million USD | 53.28% |
| 2007 Q3 | 42.88 Million USD | 9.42% |
| 2007 Q2 | 39.19 Million USD | 11.05% |
| 2007 Q1 | 35.29 Million USD | 23.78% |
| 2006 FY | 28.51 Million USD | 62.93% |
| 2006 Q4 | 28.51 Million USD | 11.75% |
| 2006 Q3 | 25.51 Million USD | 18.39% |
| 2006 Q2 | 21.55 Million USD | 6.26% |
| 2006 Q1 | 20.28 Million USD | 0.0% |
| 2005 Q2 | - USD | -100.0% |
| 2005 Q3 | 17.97 Million USD | 0.0% |
| 2005 Q1 | 84.00 USD | 0.0% |
| 2005 FY | 17.5 Million USD | 20834507.14% |
| 2004 Q4 | 84.00 USD | 0.0% |
| 2004 FY | 84.00 USD | -99.97% |
| 2004 Q1 | 3592.00 USD | 3891.11% |
| 2004 Q2 | 84.00 USD | -97.66% |
| 2004 Q3 | 84.00 USD | 0.0% |
| 2003 Q1 | 341.11 Thousand USD | -8.91% |
| 2003 FY | 298.62 Thousand USD | -29.85% |
| 2003 Q2 | 298.62 Thousand USD | -12.45% |
| 2003 Q4 | 90.00 USD | -74.5% |
| 2003 Q3 | 353.00 USD | -99.88% |
| 2002 Q1 | 832.97 Thousand USD | 43.19% |
| 2002 Q2 | 425.67 Thousand USD | -48.9% |
| 2002 Q3 | 425.13 Thousand USD | -0.13% |
| 2002 Q4 | 374.48 Thousand USD | -11.91% |
| 2002 FY | 425.67 Thousand USD | 0.0% |
| 2001 Q4 | 581.72 Thousand USD | -1.15% |
| 2001 Q3 | 588.49 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| cbdMD, Inc. | 16.19 Million USD | -1.691% |
| cbdMD, Inc. | 16.19 Million USD | -1.691% |
| Zomedica Corp. | 253.19 Million USD | 93.495% |